Invention Grant
- Patent Title: C-3 and C-17 modified triterpenoids as HIV-1 inhibitors
-
Application No.: US16071925Application Date: 2017-02-02
-
Publication No.: US10421774B2Publication Date: 2019-09-24
- Inventor: Jie Chen , Yan Chen , Ira B. Dicker , Richard A. Hartz , Nicholas A. Meanwell , Beata Nowicka-Sans , Alicia Regueiro-Ren , Sing-Yuen Sit , Ny Sin , Jacob Swidorski , Brian Lee Venables
- Applicant: ViiV HEALTHCARE UK (NO.5) LIMITED
- Applicant Address: GB Brentford, Middlesex
- Assignee: ViiV HEALTHCARE UK (NO.5) LIMITED
- Current Assignee: ViiV HEALTHCARE UK (NO.5) LIMITED
- Current Assignee Address: GB Brentford, Middlesex
- Agent Robert H. Brink; Kathryn A. Lutomski; Edward R. Gimmi
- International Application: PCT/IB2017/050568 WO 20170202
- International Announcement: WO2017/134596 WO 20170810
- Main IPC: C07J53/00
- IPC: C07J53/00 ; C07J63/00 ; C12N9/50 ; A61P31/18

Abstract:
Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, betulinic acid derivatives that possess unique antiviral activity are provided as HIV maturation inhibitors, as represented by compounds of Formula I: These compounds are useful for the treatment of HIV and AIDS.
Public/Granted literature
- US20190031709A1 C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS Public/Granted day:2019-01-31
Information query